West Pharmaceutical Services (WST) Non Operating Income (2016 - 2025)
Historic Non Operating Income for West Pharmaceutical Services (WST) over the last 15 years, with Q3 2025 value amounting to -$6.9 million.
- West Pharmaceutical Services' Non Operating Income fell 5681.82% to -$6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.9 million, marking a year-over-year decrease of 11776.65%. This contributed to the annual value of -$21.0 million for FY2024, which is 3312.1% up from last year.
- Per West Pharmaceutical Services' latest filing, its Non Operating Income stood at -$6.9 million for Q3 2025, which was down 5681.82% from -$5.2 million recorded in Q2 2025.
- In the past 5 years, West Pharmaceutical Services' Non Operating Income registered a high of $9.7 million during Q3 2023, and its lowest value of -$50.0 million during Q3 2022.
- Moreover, its 5-year median value for Non Operating Income was -$4.0 million (2023), whereas its average is -$6.7 million.
- Per our database at Business Quant, West Pharmaceutical Services' Non Operating Income soared by 19000.0% in 2021 and then crashed by 267777.78% in 2022.
- Over the past 5 years, West Pharmaceutical Services' Non Operating Income (Quarter) stood at -$11.5 million in 2021, then skyrocketed by 115.65% to $1.8 million in 2022, then tumbled by 594.44% to -$8.9 million in 2023, then fell by 14.61% to -$10.2 million in 2024, then skyrocketed by 32.35% to -$6.9 million in 2025.
- Its Non Operating Income stands at -$6.9 million for Q3 2025, versus -$5.2 million for Q2 2025 and -$20.6 million for Q1 2025.